SCHEMBL5554897

SCHEMBL5554897

CCc1cc(C(=O)O)c(NC(N)=O)s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.60
GRIN2C Q14957 1/20 0.59
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MAPT P10636 8/20 0.53
GAA P10253 3/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
KDM4E B2RXH2 4/20 0.51
HSD17B10 Q99714 4/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
POLB P06746 2/20 0.50
CYP2C9 P11712 2/20 0.49
CYP1A2 P05177 1/20 0.49
IKBKB O14920 2/20 0.48
NPSR1 Q6W5P4 3/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10135139 0.89 ALDH1A1 (0.61) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2
SCHEMBL6317837 0.84 ALDH1A1 (0.60) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2
SCHEMBL13431200 0.81 ALDH1A1 (0.66) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2
SCHEMBL13431179 0.80 ALDH1A1 (0.53) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2
SCHEMBL5555718 0.79 ALDH1A1 (0.62) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2
SCHEMBL3083629 0.78 IKBKB (0.50) ALDH1A1KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL2759478 0.76 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL7906323 0.75 GRIN2C (1.00) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2
SCHEMBL5556399 0.75 IKBKB (0.46) GRIN2CKMT2AMEN1MAPTRAB9A
SCHEMBL5551087 0.74 MAPK1 (0.53) ALDH1A1GRIN2CKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010556-A1 Thiophene derivatives as chk 1 inhibitors ASTRAZENECA AB (SE) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010556-A1 Thiophene derivatives as chk 1 inhibitors CHEK1, CHKA, CHEK2 ALDH1A1 2326/4885GRIN2C 4559/4885KMT2A 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.